TY - JOUR
T1 - Peptidomic analysis of rat urine using capillary electrophoresis coupled to mass spectrometry
AU - Frommberger, Moritz
AU - Zürbig, Petra
AU - Jantos, Justyna
AU - Krahn, Thomas
AU - Mischak, Harald
AU - Pich, Andreas
AU - Just, Ingo
AU - Schmitt-Kopplin, Philippe
AU - Schiffer, Eric
PY - 2007/7
Y1 - 2007/7
N2 - We have established and validated a protocol for the peptidomic analysis of rat urine using CE coupled to MS (CE-MS). In the first experiments, the reproducibility of the CE-MS set-up and of the established preparation procedure were assessed. To establish a first rat urinary peptidome map, samples were also analyzed using CE-FT-ICR. The subsequent analysis of independent samples from two different strains (WISTAR and CD) indicated strain-specific differences, which were validated in a blinded assessment. MS/MS revealed the presence of specific fragments from well-known urinary rat peptides, such as collagens, alpha-1-antitrypsin, and serum albumin. The CE-MS-based peptidomics platform may provide novel insights into body fluids of animal models, such as rat or mice. Together with peptide identification, the technology appears to be an excellent, complimentary, and non-invasive tool to analyze toxicological or other (patho)physiological effects of pharmaceutical compounds in animal models.
AB - We have established and validated a protocol for the peptidomic analysis of rat urine using CE coupled to MS (CE-MS). In the first experiments, the reproducibility of the CE-MS set-up and of the established preparation procedure were assessed. To establish a first rat urinary peptidome map, samples were also analyzed using CE-FT-ICR. The subsequent analysis of independent samples from two different strains (WISTAR and CD) indicated strain-specific differences, which were validated in a blinded assessment. MS/MS revealed the presence of specific fragments from well-known urinary rat peptides, such as collagens, alpha-1-antitrypsin, and serum albumin. The CE-MS-based peptidomics platform may provide novel insights into body fluids of animal models, such as rat or mice. Together with peptide identification, the technology appears to be an excellent, complimentary, and non-invasive tool to analyze toxicological or other (patho)physiological effects of pharmaceutical compounds in animal models.
KW - Biomarker
KW - CE-MS
KW - Rat
KW - Urine
UR - http://www.scopus.com/inward/record.url?scp=38349107355&partnerID=8YFLogxK
U2 - 10.1002/prca.200700195
DO - 10.1002/prca.200700195
M3 - Article
AN - SCOPUS:38349107355
SN - 1862-8346
VL - 1
SP - 650
EP - 660
JO - Proteomics - Clinical Applications
JF - Proteomics - Clinical Applications
IS - 7
ER -